Supriya Lifescience IPO will open on 16th December 2021. Supriya Lifescience Ltd. is a cGMP compliant API Manufacturing Organization with leadership position in it’s category. Let’s analyse this IPO in detail.

List of Topic Covered
Key Features of Supriya Lifescience IPO
- Supriya Lifescience IPO will open on 16th Dec 2021
- You can apply in this IPO from 16th Dec 2021 to 20th Dec 2021
- Issue Price band of the company is Rs. 265 – 274 per equity share.
- This IPO comprises Fresh equity shares of worth ₹ 200 crores and an offer for sale (OFS) of equity shares worth ₹ 500 crores by promoters and existing shareholders.
- It has a minimum 54 shares in one lot and you have to spend a minimum ₹14,796 for 1 lot.
- Supriya Lifescience IPO is looking to raise ₹ 700 crores through this IPO.
What is Supriya Lifescience Limited ?
- Started in 1987, Supriya Lifescience Ltd. has a well-established presence in API Manufacturing.
- They have products in various therapeutic segments like – Antihistamine, Anti-Allergics, Vitamins, Anesthetics, Anti-Asthmatics etc.
- Company is spread across an area of 47000 sq.m. with delineated areas for warehouse, QA, QC, R & D, production and finished products.
- Supriya Lifescience Ltd. is backed by strong R&D, 14 active USDMFs, 8 active CEPs & World wide compliant facilities (EMA, US FDA, WHO, PMDA, TGA, KFDA, ANVISA).
- Dr. Satish Waman Wagh is the Chairman and MD of the company.
- On the revenue front, the company is just doubling their profits on a year on year basis and a very strong and positive sign for investors.
Grey Market Premium of Supriya Lifescience IPO GMP
Grey market is an unregulated market to trade ipo shares before listing. MapmyIndia IPO price band is placed at ₹ 265 – ₹ 274 but the grey market premium of this share is currently 94.89% up i.e. at ₹ 260. So the share price of RateGain Travel IPO in the grey market is ₹ 534 (274 + 260).
Supriya Lifescience IPO Live Subscription Status.
Data coming soon.
Supriya Lifescience IPO Conditions to know before Investing, Date, Lot Size, Allotment
IPO Start Date | 16 December 2021 |
IPO Close Date | 20 December 2021 |
Share Allotment Date | 23 December 2021 |
Refunds Date | 24 December 2021 |
Credit to Demat Account Date | 27 December 2021 |
IPO Listing Date | 28 December 2021 |
Fresh Equity Share Issue | Approx ₹ 200 crores |
Offer For Sale (OFS) Equity Share | Approx ₹ 500 crores |
Face Value | ₹ 2 Per Equity Share |
Price Band | ₹ 265 – ₹ 274 Per Equity Share |
Retail Quota Share | 10% |
QIB Quota | 75% |
NII Quota | 15% |
Listing on | NSE & BSE |
Minimum Lot Size | 54 Share in 1 Lot |
Minimum Amount | ₹ 14,796 For 1 Lot |
Maximum Lot Size | 702 Shares (13 Lot) |
Maximum Amount | ₹ 1,92,348 (For 14 Lot) |
Employee Discount | NA |
DRHP | View |
Supriya Lifescience IPO Financial Report of 2019,2020 & 2021
Company is consistently making profit for the last three years which is a strong positive sign for the investors.
Year | Revenue | Expense | PAT (Profit After Tax) |
2021 | ₹ 396 | ₹ 218 | ₹ 123.8 |
2020 | ₹ 323 | ₹ 213 | ₹ 73.37 |
2019 | ₹ 286 | ₹ 213 | ₹ 39.42 |
Retail Investors, QIB & NII quota in Supriya Lifescience IPO
Supriya Lifescience IPO’s 75% quota is reserved for the QIB category. 15% quota is reserved for NII Category and 10% quota is reserved for retail investors.
How to Apply in Supriya Lifescience IPO
- You can apply for the Supriya Lifescience IPO through the ASBA facility available in your bank account.
- Just login to your online banking. GO to the IPO section and apply for Supriya Lifescience Limited IPO
- Also you can apply this IPO through your trading account
- One more way to apply in this IPO is through forms which you can download from NSE and BSE website.
- After downloading forms, fill it properly and submit it to the respective banks or to your broker.
How to apply for the Supriya Lifescience IPO through Zerodha?
- Login to your console in Zerodha through desktop or app.
- Then go to your portfolio and click on IPO.
- You will see Supriya Lifescience limited IPO.
- Then click on the bid button.
- After this enter your UPI ID, price and quantity (lot size)
- Click the submit button.
- At last you have to go to your UPI app to approve the mandate.
How to apply for the Supriya Lifescience IPO through Upstox?
- Login to your Upstox account through desktop or app.
- You will see the name Supriya Lifescience limited IPO
- Then hit the bid button.
- Click the submit button.
- At last you have to go to your UPI app to approve the mandate.
Allotment Status For Supriya Lifescience IPO
You can check MapmyIndia IPO allotment status on Registrar and Transfer Agent Website
Also you can check the allotment status on NSE Website
Supriya Lifescience IPO Promoters
- Satish Waman Wagh
Supriya Lifescience IPO Lead Managers
- Axis Capital Limited
- ICICI Securities Limited
Supriya Lifescience Limited contact information
Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
- Phone: +91-22-40332727
- Email: cs@supriyalifescience.com
- Website: https://supriyalifescience.com/
Supriya Lifescience IPO Registrar Contact Information
Link Intime India Private Ltd
- Phone: +91-22-4918 6270
- Email: supriyalife.ipo@linkintime.co.in
- Website: https://linkintime.co.in/
Paisa kaudi recommendation on Supriya Lifescience IPO
Supriya Lifescience is a leading manufacturer of API. Price range is convincing. GMP is awesome so far. Can be considered for listing gains and for long term as well. keep checking the GMP and subscription status for more clearance.
I hope this covers all the points on Supriya Lifescience Ltd. Any feedback or comment is welcome. We will get back to you shortly.
Click here to check all the upcoming IPO Review and details
Live IPO Review
Read Review of HP Adhesives IPO | Click Here |
Read Review of Data Patterns IPO | Click Here |
Read Review of MedPlus Health IPO | Click Here |
Read Review of MapmyIndia IPO | Click Here |
Read Review of Shriram Properties Ltd IPO | Click Here |